Tecan Group AG/Fr. TECN
1D1W1MYTD1Y5YMAX
Capital at risk
About Tecan Group AG
Tecan Group AG is a Switzerland-based company operating in the life sciences industry, primarily providing laboratory instruments and solutions for automated workflows. Founded in 1980 and headquartered in Männedorf, Switzerland, the company designs and manufactures a range of products including liquid handling and robotic workflow solutions, microplate readers, and various laboratory software applications. Tecan's products serve laboratories in biopharmaceuticals, forensics, and diagnostics sectors, enhancing productivity and precision in research processes. Leveraging its technological expertise, Tecan emphasizes modular and scalable solutions that cater to diverse laboratory needs globally. Its strategic positioning revolves around innovation in automation technology to improve laboratory efficiency.
- Ticker
- Fr. TECN
- Sector
- Health
- Primary listing
- XSWX
- Employees
- 3,000
- Headquarters
- Männedorf, Switzerland
- Website
- www.tecan.com
Tecan Group AG Metrics
BasicAdvanced
CHF 2.6B
-
-CHF 9.30
1.08
CHF 3.00
0.70%
Price and volume
Market cap
CHF 2.6B
Beta
1.08
52-week high
CHF 215.00
52-week low
CHF 110.60
Average daily volume
57K
Dividend rate
CHF 3.00
Financial strength
Current ratio
2.316
Quick ratio
1.495
Long term debt to equity
0.182
Total debt to equity
0.192
Interest coverage (TTM)
15.09%
Profitability
EBITDA (TTM)
73.162
Gross margin (TTM)
34.06%
Net profit margin (TTM)
-13.36%
Operating margin (TTM)
4.55%
Effective tax rate (TTM)
-7.05%
Revenue per employee (TTM)
CHF 290,000
Management effectiveness
Return on assets (TTM)
1.38%
Return on equity (TTM)
-9.69%
Valuation
Price to revenue (TTM)
3.068
Price to book
2.37
Price to tangible book (TTM)
9.19
Price to free cash flow (TTM)
64.594
Free cash flow yield (TTM)
1.55%
Free cash flow per share (TTM)
3.307
Dividend yield (TTM)
1.40%
Forward dividend yield
0.70%
Growth
Revenue change (TTM)
-3.98%
Earnings per share change (TTM)
-287.88%
3-year revenue growth (CAGR)
-7.55%
10-year revenue growth (CAGR)
6.23%
3-year earnings per share growth (CAGR)
3.12%
10-year earnings per share growth (CAGR)
7.01%
3-year dividend per share growth (CAGR)
1.14%
10-year dividend per share growth (CAGR)
5.54%
Upcoming events
No upcoming events
Funds containing Tecan Group AG
AllUSDEURGBP
Fund name | Fund size | Fr. TECN weighting |
|---|---|---|
iShares Healthcare Innovation$HEAL | $1.4B | 0.34% |
iShares Healthcare Innovation€2B78 | €1.2B | 0.34% |
iShares Healthcare Innovation£DRDR | £1B | 0.34% |
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.21% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.21% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.